References
- Whitehouse CA. Crimean-Congo haemorrhagic fever. Antiviral Res 2004; 64: 145–60
- Fischer-Hoch SP, Khan JA, Rehman S, Mirza S, Khurshid M, McCormick JB. Crimean-Congo haemorrhagic fever treated with oral ribavirin. Lancet 1995; 346: 472–5
- Mardani M, Keshtkar-Jahromi M. Crimean-Congo haemorrhagic fever. Arch Iranian Med 2007; 10: 204–14
- van Eeden PJ, van Eeden SF, Joubert JR, King JB, van de Wal BW, Michell WL. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg hospital. Part II. Management of patients. S Afr Med J 1985; 68: 718–21
- Ergonul O. Crimean-Congo haemorrhagic fever. Lancet 2006; 6: 203–14
- Burney MI, Ghafoor A, Saleen M, Webb PA, Casals J. Nosocomial outbreak of viral haemorrhagic fever caused by Crimean Congo haemorrhagic fever virus in Pakistan, January 1976. Am J Trop Med Hyg 1980; 29: 941–7
- van Eeden PJ, Joubert JR, van de Wal BW, King JB, de Kock A, Groenewald JH. A nosocomial outbreak of Crimean Congo haemorrhagic fever at Tygerberg hospital. Part I. Clinical features. S Afr Med J 1985; 68: 711–7
- Athar MN, Khalid MA, Ahmad AM, Bashir N, Baqai HZ, Ahmad M, et al. Crimean Congo haemorrhagic fever outbreak in Rawalpindi, Pakistan, February 2002: contact tracing and risk assessment. Am J Trop Med Hyg 2005; 72: 471–3
- Smego RA, Jr, Sarwari AR, Siddiqui AR. Crimean Congo haemorrhagic fever: prevention and control limitations in a resource-poor country. Clin Infect Dis 2004; 38: 1731–5
- Harxhi A, Pilaca A, Delia Z, Pano K. Crimean Congo haemorrhagic fever: a case of nosocomial transmission. Infection 2005; 33: 295–6
- Karti SS, Odabasi Z, Korten V, Yilmaz M, Sonmez M, Caylan R, et al. Crimean Congo haemorrhagic fever in Turkey. Emerg Infect Dis 2004; 10: 1379–84
- Altaf A, Luby S, Ahmed AJ, Zaidi N, Khan AJ, Mirza S, et al. Outbreak of Crimean Congo haemorrhagic fever in Quetta, Pakistan: contact tracing and risk assessment. Trop Med Int Health 1998; 3: 878–82
- Centers for Disease Control and Prevention. Interim guidance for managing patients with suspected viral haemorrhagic fever in US hospitals. http://www.cdc.gov/ncidod/dhqp/bp_vhf_ interimGuidance.html, , (accessed Dec 7, 2008).
- Weber DJ, Rutala WA. Risks and prevention of nosocomial transmission of rare zoonotic diseases. Clin Infect Dis 2001; 32: 446–56
- Tarantola A, Ergonul O, Tattevin P. Estimates and prevention of Crimean Congo hemorrhagic fever risks for health care workers. Crimean Congo Haemorrhagic Fever: a Global Perspective, O Ergonul, CA Whitehouse. Springer, Dordrecht, NL 2007; 281–94
- Ergonul O. Treatment of Crimean Congo haemorrhagic fever. Antiviral Res 2008; 78: 125–31
- Mardani M, Jahromi MK, Naieni KH, Zeinali M. The efficacy of oral ribavirin in the treatment of Crimean Congo haemorrhagic fever in Iran. Clin Infect Dis 2003; 36: 1613–8
- Guidelines for Crimean Congo haemorrhagic fever (CCHF). http://nih.org.pk/SOPs%20 andGuidelines/CCHF%20guidelines.htm, , (accessed Dec 7, 2008).